Skyhawk Therapeutics Stock

skyhawktx.comHealthcare / BioTech & PharmaFounded: 2015

Skyhawk Therapeutics, founded in 2016, is a biotechnology company with the aim of discovering, developing, and commercializing innovative therapies utilizing its novel SkySTARTM (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA) platform. By harnessing the power of RNA-targeting technology, Skyhawk Therapeutics strives to address unmet medical needs and bring transformative therapies to market. Skyhawk Therapeutics is headquartered in Waltham, Massachusetts.

Register for Details

For more details on financing and valuation for Skyhawk Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Skyhawk Therapeutics.

Register Today

Team

Management Team

Kathleen McCarthy
Co-Founder & Chief Scientific Officer
Sergey Paushkin Ph.D
Senior Vice President, Discovery Biology
Maura McCarthy
Senior Vice President, Corporate Development
William Haney
Co-Founder, Chief Executive Officer & Chairman
Clinton Musil
Chief Financial Officer

Other companies like Skyhawk Therapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B